Marine–Lenhart Syndrome: Functional Autonomy and Malignancy Risk Are Distinct Diagnostic Dimensions
European Thyroid Journal · 18.11.2026
DOI: 10.1530/etj-26-0411 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Thyroid Journal, online erschienen am 18.11.2026. Verfasst von Shinichiro M Koga. Beteiligte Einrichtung: Department of Diabetes, Endocrinology and Metabolism, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital , Tokyo, Japan. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Marine–Lenhart syndrome (MLS), characterized by Graves’ disease coexisting with autonomously functioning thyroid nodule (s), presents distinctive diagnostic and therapeutic challenges. Recent emphasis on thyroid scintigraphy has highlighted the potential “unmasking” of initially suppressed nodules. However, this phenomenon should not be interpreted as evidence that every initially cold nodule represents a latent autonomously functioning nodule, because scintigraphic appearance reflects functional status at a particular point in time and predictors of subsequent autonomous function remain incompletely defined. Moreover, functional autonomy and malignancy risk represent distinct diagnostic dimensions. Scintigraphy characterizes thyroid function but cannot establish histological benignity. Conversely, although hyperfunctioning nodules have a very low but non-zero risk of malignancy and routine cytological evaluation is generally not recommended, scintigraphic hyperfunction alone does not establish histological benignity. Ultrasonographic risk assessment remains complementary to functional imaging, and fine-needle aspiration should be considered when clinically appropriate, particularly in the presence of highly suspicious or discordant ultrasonographic findings or suspicious cervical lymph nodes. Similarly, observations that some patients require higher radioiodine activities or repeat treatment should not be equated with an established universal dosing strategy, given the predominantly case-based evidence underlying the MLS literature. Nuclear medicine imaging remains indispensable for functional characterization in MLS, but its interpretation should recognize “unmasking” as a changing functional phenotype rather than a definitive diagnostic endpoint.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diabetes, Endocrinology and Metabolism, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital , Tokyo, Japan.
ORCID-Profile: Shinichiro M Koga
Zitieren
APA
Koga, S. M. (2026). Marine–Lenhart Syndrome: Functional Autonomy and Malignancy Risk Are Distinct Diagnostic Dimensions. European Thyroid Journal. https://doi.org/10.1530/etj-26-0411
Vancouver
Koga SM. Marine–Lenhart Syndrome: Functional Autonomy and Malignancy Risk Are Distinct Diagnostic Dimensions. European Thyroid Journal. 2026. doi:10.1530/etj-26-0411
BibTeX
@article{Koga2026,
author = {Koga, Shinichiro M},
title = {Marine–Lenhart Syndrome: Functional Autonomy and Malignancy Risk Are Distinct Diagnostic Dimensions},
journal = {European Thyroid Journal},
year = {2026},
doi = {10.1530/etj-26-0411}
}
EUVIMED